# Pilot Study Comparing the Efficacy and Safety of a New Pain Patch and Placebo in Delayed Onset Muscle Soreness (DOMS)

> **NCT02602353** · PHASE2 · COMPLETED · sponsor: **Lead Chemical Co., Ltd.** · enrollment: 42 (actual)

## Conditions studied

- Delayed Onset Muscle Soreness

## Interventions

- **DRUG:** Loxoprofen Pain Patch
- **DRUG:** Placebo Patch
- **DRUG:** No Treatment

## Key facts

- **NCT ID:** NCT02602353
- **Lead sponsor:** Lead Chemical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2016-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02602353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02602353, "Pilot Study Comparing the Efficacy and Safety of a New Pain Patch and Placebo in Delayed Onset Muscle Soreness (DOMS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02602353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*